Mental health startup Cerebral is under investigation by the US Department of Justice over its prescribing of controlled substances like Adderall and Xanax. The company received a grand jury subpoena asking for documents from the US Attorney for the Eastern District of New York on May 4, Insider first reported.

Parents with ADHD may worry about their children dealing with similar challenges. But you can teach your kids how to thrive while coping with symptoms yourself.

In the past 30 years, adult ADHD has gone from barely recognized to a well-established disorder with evidence-based treatment options. In my 20 years studying and treating ADHD in adults, it’s been exciting to witness and, in a small way, contribute to advances in evidence-based treatment for adult ADHD made by researchers around the world.

Online pharmacy company Truepill Inc. said it is temporarily halting prescriptions for Adderall and other controlled substances used to treat attention-deficit hyperactivity disorder, and partner Cerebral Inc. told its clinicians to direct those orders to patients’ local pharmacies.

When you’re overwhelmed by a million tasks and end up doing nothing — that’s what ADHD paralysis feels like.

Researchers are turning to a unexpected treatment for cognitive disorders: video games.

Researchers at the University of California San Diego have developed a smartphone app that could allow people to screen for Alzheimer’s disease, ADHD and other neurological diseases and disorders—by recording closeups of their eye.

Even half a century after a drug comes on the market, scientists can still learn new things about how it works. New research from University of Pittsburgh neuroscientists provides a rare look at how Ritalin affects activity in the brains of animals, providing a deeper understanding of how groups of brain cells govern attention and…

Research led by King’s College London and South London and Maudsley NHS Foundation Trust has analyzed factors associated with self-harm in over 111,000 adolescents aged 11-17 years old. Published in BMC Medicine the study found that the risk for self-harm presenting to hospital emergency departments was nearly three times higher for boys with autism spectrum…

The mental health startup Cerebral said it would stop prescribing controlled substances to treat ADHD for new patients on Wednesday, a week after an ex-executive filed a lawsuit alleging he was fired in retaliation for speaking up about unethical business practices, including the company’s practice of overprescribing stimulants in order to retain patients.

Key takeaways: In March 2022, Xelstrym (dextroamphetamine) became the first FDA-approved amphetamine patch to treat ADHD in adults and children at least 6 years of age. Common side effects of Xelstrym include a smaller appetite, trouble sleeping, and headache. More serious side effects include dependence, heart problems, and serotonin syndrome. Xelstrym will probably be available…

The FDA expanded the approval of viloxazine extended-release capsules (Qelbree) to include adults with ADHD, Supernus Pharmaceuticals announced. Now indicated for adults ages 18 and older, viloxazine is the first nonstimulant ADHD option for adults in 20 years. The agent was initially approved in April 2021 for children ages of 6 to 17.